Webinar on demand
Webinar on demand
High-content analysis of disease models and toxicology studies using C. elegans
High-content analysis of disease models and toxicology studies using C. elegans
our focus
WHAT OUR USERS ARE SAYING
“The Newormics vivoCube and vivoChip system has revolutionized my imaging days! It’s easy to set up, fits nicely into our space, and is very user-friendly. And it’s so fast! I can image and score a full chip in about 40 minutes!”
Dr. Lotti Brose
Pierce-Shimomura Lab, University of Texas at Austin
“Day 2 of using the vivoCube from Newormics ! Still learning some tricks to improve/perfect the set-up process, but super excited to do science with this new toy! Huge thanks to Newormics support for getting us started.”
Joseph Liang
Rankin lab, University of British Columbia
“Newormics deliver on their promises, and have enabled our lab to perform high-throughput imaging in C. elegans. Their system is very easy to set up and use, the worms are very robustly oriented, and the chip is suitable for even high-resolution imaging!”
Steven Ban
Saul Kato Lab, UCSF
“I found the L4-YA chip from Newormics extremely effective in immobilizing L4s and adults for live imaging even without supplementing the system with any anesthetics. The imaged worms also seemed to be in good condition when the imaging session was concluded...”
Nikhil Mishra
Conradt Lab, LMU Munich
“Newormics LLC...unveiled their microfluidic chips for easy immobilization and imaging of up to 5000 worms, proving yet again that you are only limited by your imagination! We already beta tested their dual chip that can immobilize up to 80 worms in tandem, across two sets of microfluidic channels, and it was awesome!”
Dr. Sangeetha Iyer
Director of Preclinical Development, Perlara
PRESENT CUSTOMERS INCLUDE
OUR TEAM
We are a team of innovators from Austin in the fields of microfluidics, life-science imaging, and chemical screening.
Chief Executive Officer, Co-Founder
Adela Ben-Yakar, PhD
Dir. of Manufacturing, Co-founder
Evan Hegarty, MSE
Head of Operations
Gina Lento, PhD
Research Scientist
Adam Laing, PhD
Automation & Manufacturing Engineer
Jacob Moore, PhD
Research Scientist
Yunki Im, PhD
LATEST NEWS
Newormics awarded SBIR Phase II grant from NIMH
Newormics is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) for the continued development of the company’s in vivo imaging and screening technologies.
Newormics Announces Intent to Grant Utility Patent on the vivoChip by the European Patent Office
Newormics LLC, a developer of the first high-throughput, high-content screening platforms for use with in vivo small animal models, announced that the European Patent Office (EPO) intends to grant a patent covering the vivoChip® technology, the device design and use for C. elegans studies.
Newormics resumes operations
At our Newormics location in Austin, TX, we have been allowed to re-open. We have resumed operations in our lab and in our manufacturing facility.